Effects of Clostridium difficile toxins on epithelial cell barrier

Annals of the New York Academy of Sciences

Volumn 915, Issue , 2000, Pages 347-356

  Pothoulakis, Charalabos ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTENSIN; SUBSTANCE P;

COLITIS; CONFERENCE PAPER; CYTOKINE RELEASE; DIARRHEA; ENZYME ACTIVATION; HUMAN; INTESTINE EPITHELIUM CELL; MACROPHAGE ACTIVATION; MAST CELL; NONHUMAN; PATHOGENESIS; TIGHT JUNCTION;

CLOSTRIDIUM DIFFICILE;

EID: 0034525733     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05263.x     Document Type: Conference Paper

References (54)

1. Clostridium difficile colitis
2. Nosocomial acquisition of Clostridium difficile infection
3. Pathogenesis of Clostridium difficile-associated diarrhoea
4. Neurons and mast cells modulate secretory and inflammatory responses to enterotoxins
5. Molecular characterization of the Clostridium difficile toxin A gene
6. Cloning and expression of the toxin B gene of Clostridium difficile
7. Effect of toxins A and B of Clostridium difficile on rabbit ileum and colon
8. Differential effects of Clostridium difficile toxins A and B on rabbit ileum
9. Clostridium difficile toxin A and its effects on cells
10. Toxin A of Clostridium difficile is a potent cytotoxin
11. Cell surface binding site for Clostridium difficile enterotoxin: Evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta-4GlcNAc
12. Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: Physiologic and pathophysiologic basis
13. Clostridium difficile toxin excites enteric neurons and suppresses inhibitory noradrenergic neurotransmission in the submucous plexus of guinea-pig small intestine
14. Purification and properties of Clostridium difficile cytotoxin B
15. 84 monolayers
16. Effects of epidermal growth factor and Clostridium difficile toxin B in a model of mucosal injury
17. IL-8 release and neutrophil activation by Clostridium difficile toxin A-exposed human monocytes
18. Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B
19. Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes
20. Enterotoxin A of Clostridium difficile and α-Gal epitopes
21. Clostridium difficile toxin B induces reorganization of actin, vinculin, and talin in cultured cells
22. Clostridium difficile toxin B acts on the GTP-binding protein Rho
23. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins
24. Involvement of ras-related Rho proteins in the mechanism of action of Clostridium difficile toxin A and B
25. Glucosylation of Rho proteins by Clostridium difficile toxin B
26. Clostridium difficile toxin A perturbs cytoskeletal structure and junction permeability in cultured human epithelial cells
27. Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia
28. - secretion
29. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro
30. Rabbit sucrase-isomaltase contains a functional receptor for Clostridium difficile toxin A
31. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: Induction of interleukin 8 production and apoptosis after cell detachment
32. Epidermal growth factor attenuates Clostridium difficile toxin A- and B-induced damage of human colonic mucosa in vitro
33. Trefoil peptides protect intestinal epithelial monolayer/barrier function: Cooperative interaction with mucin glycoprotein
34. Comparative study of Clostridium difficile toxin A and cholera toxin in rabbit ileum. Role of prostaglandins and leukotrienes
35. Substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats
36. Participation of reactive oxygen metabolites in Clostridium difficile toxin A-induced enteritis in rats
37. Neutrophil recruitment in Clostridium difficile toxin A enteritis
38. CGRP upregulation in dorsal root ganglia and ileal mucosa during Clostridium difficile toxin A-induced enteritis
39. Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholera enterotoxin
40. CP-96,345, a substance P antagonist, inhibits rat intestinal responses to toxin A but not cholera toxin
41. Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in the rat ileum
42. Increased substance P receptor expression in intestinal epithelial cells during Clostridium difficile toxin A enteritis in rats
43. NK-1 receptor is required in Clostridium difficile-induced enteritis
44. Increased substance P receptor expression by blood vessels and lymphoid aggregates in Clostridium difficile-induced pseudomembranous colitis
45. Ketotifen inhibits toxin A-induced enteritis in rat ileum
46. Mast cell involvement in Clostridium difficile toxin A-induced intestinal fluid secretion and neutrophil recruitment in mice
47. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves
48. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa
49. Neurotensin elevates hematocrit and plasma levels of the leukotrienes LTB4, LTC4, LTD4, and LTE4, in anesthetized rats
50. Evidence for a neurotensin receptor in rat serosal mast cells
51. A neurotensin antagonist, SR 48692, inhibits colonic responses to immobilization stress in rats
52. Neurotensin is a proinflammatory peptide in colonic inflammation
53. Clostridium difficile toxin A stimulates macrophage inflammatory protein-2 production in rat intestinal epithelial cells
54. p38 MAP kinase acitvation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production and enteritis